<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37540751</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2375-2548</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>31</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>04</Day></PubDate></JournalIssue><Title>Science advances</Title><ISOAbbreviation>Sci Adv</ISOAbbreviation></Journal><ArticleTitle>Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>eadf6895</StartPage><MedlinePgn>eadf6895</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">eadf6895</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.adf6895</ELocationID><Abstract><AbstractText>The cytoplasmic aggregation of TAR DNA binding protein-43 (TDP-43), also known as TDP-43 pathology, is the pathological hallmark of amyotrophic lateral sclerosis (ALS). However, the mechanism underlying TDP-43 cytoplasmic mislocalization and subsequent aggregation remains unclear. Here, we show that TDP-43 dimerization/multimerization is impaired in the postmortem brains and spinal cords of patients with sporadic ALS and that N-terminal dimerization-deficient TDP-43 consists of pathological inclusion bodies in ALS motor neurons. Expression of N-terminal dimerization-deficient mutant TDP-43 in Neuro2a cells and induced pluripotent stem cell-derived motor neurons recapitulates TDP-43 pathology, such as Nxf1-dependent cytoplasmic mislocalization and aggregate formation, which induces seeding effects. Furthermore, TDP-DiLuc, a bimolecular luminescence complementation reporter assay, could detect decreased N-terminal dimerization of TDP-43 before TDP-43 pathological changes caused by the transcription inhibition linked to aberrant RNA metabolism in ALS. These findings identified TDP-43 monomerization as a critical determinant inducing TDP-43 pathology in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oiwa</LastName><ForeName>Kotaro</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7797-6384</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Aichi 464-8601, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8560, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Seiji</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8038-7919</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Aichi 464-8601, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience and Pathobiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8560, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onodera</LastName><ForeName>Kazunari</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3274-0260</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8560, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neural iPSC Research, Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Aichi 480-1195, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Aichi Medical University School of Medicine, Nagakute, Aichi 480-1195, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iguchi</LastName><ForeName>Yohei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8560, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinoshita</LastName><ForeName>Yukako</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7635-9242</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Aichi 464-8601, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komine</LastName><ForeName>Okiru</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-0845-7358</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Aichi 464-8601, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience and Pathobiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8560, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobue</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Aichi 464-8601, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience and Pathobiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8560, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Interactive Research and Academia Industry Collaboration Center, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okada</LastName><ForeName>Yohei</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-5253-8556</Identifier><AffiliationInfo><Affiliation>Department of Neural iPSC Research, Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Aichi 480-1195, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Aichi Medical University School of Medicine, Nagakute, Aichi 480-1195, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsuno</LastName><ForeName>Masahisa</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9453-9311</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8560, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Glyco-core Research (iGCORE), Nagoya University, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamanaka</LastName><ForeName>Koji</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4655-0035</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Aichi 464-8601, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience and Pathobiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8560, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Glyco-core Research (iGCORE), Nagoya University, Aichi, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for One Medicine Innovative Translational Research (COMIT), Nagoya University, Nagoya, Aichi, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Adv</MedlineTA><NlmUniqueID>101653440</NlmUniqueID><ISSNLinking>2375-2548</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>4</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>4</Day><Hour>14</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37540751</ArticleId><ArticleId IdType="pmc">PMC10403219</ArticleId><ArticleId IdType="doi">10.1126/sciadv.adf6895</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J. P.&#xa0;Taylor, R. H.&#xa0;Brown Jr., D. W.&#xa0;Cleveland, Decoding ALS: From genes to mechanism. Nature 539, 197&#x2013;206 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>P.&#xa0;Tziortzouda, L.&#xa0;Van Den Bosch, F.&#xa0;Hirth, Triad of TDP43 control in neurodegeneration: Autoregulation, localization and aggregation. Nat. Rev. Neurosci. 22, 197&#x2013;208 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33654312</ArticleId></ArticleIdList></Reference><Reference><Citation>G.&#xa0;Kim, O.&#xa0;Gautier, E.&#xa0;Tassoni-Tsuchida, X. R.&#xa0;Ma, A. D.&#xa0;Gitler, ALS genetics: Gains, losses, and implications for future therapies. Neuron 108, 822&#x2013;842 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>T.&#xa0;Arai, M.&#xa0;Hasegawa, H.&#xa0;Akiyama, K.&#xa0;Ikeda, T.&#xa0;Nonaka, H.&#xa0;Mori, D.&#xa0;Mann, K.&#xa0;Tsuchiya, M.&#xa0;Yoshida, Y.&#xa0;Hashizume, T.&#xa0;Oda, TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602&#x2013;611 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>M.&#xa0;Neumann, D. M.&#xa0;Sampathu, L. K.&#xa0;Kwong, A. C.&#xa0;Truax, M. C.&#xa0;Micsenyi, T. T.&#xa0;Chou, J.&#xa0;Bruce, T.&#xa0;Schuck, M.&#xa0;Grossman, C. M.&#xa0;Clark, L. F.&#xa0;McCluskey, B. L.&#xa0;Miller, E.&#xa0;Masliah, I. R.&#xa0;Mackenzie, H.&#xa0;Feldman, W.&#xa0;Feiden, H. A.&#xa0;Kretzschmar, J. Q.&#xa0;Trojanowski, V. M.&#xa0;Lee, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130&#x2013;133 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>J.&#xa0;Sreedharan, I. P.&#xa0;Blair, V. B.&#xa0;Tripathi, X.&#xa0;Hu, C.&#xa0;Vance, B.&#xa0;Rogelj, S.&#xa0;Ackerley, J. C.&#xa0;Durnall, K. L.&#xa0;Williams, E.&#xa0;Buratti, F.&#xa0;Baralle, J.&#xa0;de Belleroche, J. D.&#xa0;Mitchell, P. N.&#xa0;Leigh, A.&#xa0;Al-Chalabi, C. C.&#xa0;Miller, G.&#xa0;Nicholson, C. E.&#xa0;Shaw, TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668&#x2013;1672 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Y.&#xa0;Shiina, K.&#xa0;Arima, H.&#xa0;Tabunoki, J.&#xa0;Satoh, TDP-43 dimerizes in human cells in culture. Cell. Mol. Neurobiol. 30, 641&#x2013;652 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20043239</ArticleId></ArticleIdList></Reference><Reference><Citation>Y. J.&#xa0;Zhang, T.&#xa0;Caulfield, Y. F.&#xa0;Xu, T. F.&#xa0;Gendron, J.&#xa0;Hubbard, C.&#xa0;Stetler, H.&#xa0;Sasaguri, E. C.&#xa0;Whitelaw, S.&#xa0;Cai, W. C.&#xa0;Lee, L.&#xa0;Petrucelli, The dual functions of the extreme N-terminus of TDP-43 in regulating its biological activity and inclusion formation. Hum. Mol. Genet. 22, 3112&#x2013;3122 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3699067</ArticleId><ArticleId IdType="pubmed">23575225</ArticleId></ArticleIdList></Reference><Reference><Citation>A.&#xa0;Wang, A. E.&#xa0;Conicella, H. B.&#xa0;Schmidt, E. W.&#xa0;Martin, S. N.&#xa0;Rhoads, A. N.&#xa0;Reeb, A.&#xa0;Nourse, D.&#xa0;Ramirez Montero, V. H.&#xa0;Ryan, R.&#xa0;Rohatgi, F.&#xa0;Shewmaker, M. T.&#xa0;Naik, T.&#xa0;Mittag, Y. M.&#xa0;Ayala, N. L.&#xa0;Fawzi, A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing. EMBO J. 37, e97452 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5830921</ArticleId><ArticleId IdType="pubmed">29438978</ArticleId></ArticleIdList></Reference><Reference><Citation>T.&#xa0;Afroz, E. M.&#xa0;Hock, P.&#xa0;Ernst, C.&#xa0;Foglieni, M.&#xa0;Jambeau, L.&#xa0;A.&#xa0;B.&#xa0;Gilhespy, F.&#xa0;Laferriere, Z.&#xa0;Maniecka, A.&#xa0;Pluckthun, P.&#xa0;Mittl, P.&#xa0;Paganetti, F.&#xa0;H.&#xa0;T.&#xa0;Allain, M.&#xa0;Polymenidou, Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat. Commun. 8, 45 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>L. L.&#xa0;Jiang, W.&#xa0;Xue, J. Y.&#xa0;Hong, J. T.&#xa0;Zhang, M. J.&#xa0;Li, S. N.&#xa0;Yu, J. H.&#xa0;He, H. Y.&#xa0;Hu, The N-terminal dimerization is required for TDP-43 splicing activity. Sci. Rep. 7, 6196 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5522446</ArticleId><ArticleId IdType="pubmed">28733604</ArticleId></ArticleIdList></Reference><Reference><Citation>M.&#xa0;Mompean, V.&#xa0;Romano, D.&#xa0;Pantoja-Uceda, C.&#xa0;Stuani, F. E.&#xa0;Baralle, E.&#xa0;Buratti, D. V.&#xa0;Laurents, Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions. J. Biol. Chem. 292, 11992&#x2013;12006 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5512090</ArticleId><ArticleId IdType="pubmed">28566288</ArticleId></ArticleIdList></Reference><Reference><Citation>H.&#xa0;Yu, S.&#xa0;Lu, K.&#xa0;Gasior, D.&#xa0;Singh, S.&#xa0;Vazquez-Sanchez, O.&#xa0;Tapia, D.&#xa0;Toprani, M. S.&#xa0;Beccari, J. R.&#xa0;Yates 3rd, S.&#xa0;Da Cruz, J. M.&#xa0;Newby, M.&#xa0;Lafarga, A. S.&#xa0;Gladfelter, E.&#xa0;Villa, D. W.&#xa0;Cleveland, HSP70 chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells. Science 371, eabb4309 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8286096</ArticleId><ArticleId IdType="pubmed">33335017</ArticleId></ArticleIdList></Reference><Reference><Citation>H.&#xa0;Sasaguri, J.&#xa0;Chew, Y. F.&#xa0;Xu, T. F.&#xa0;Gendron, A.&#xa0;Garrett, C. W.&#xa0;Lee, K.&#xa0;Jansen-West, P. O.&#xa0;Bauer, E. A.&#xa0;Perkerson, J.&#xa0;Tong, C.&#xa0;Stetler, Y. J.&#xa0;Zhang, The extreme N-terminus of TDP-43 mediates the cytoplasmic aggregation of TDP-43 and associated toxicity in vivo. Brain Res. 1647, 57&#x2013;64 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003772</ArticleId><ArticleId IdType="pubmed">27155453</ArticleId></ArticleIdList></Reference><Reference><Citation>H.&#xa0;Ederle, C.&#xa0;Funk, C.&#xa0;Abou-Ajram, S.&#xa0;Hutten, E.&#xa0;B.&#xa0;E.&#xa0;Funk, R. H.&#xa0;Kehlenbach, S. M.&#xa0;Bailer, D.&#xa0;Dormann, Nuclear egress of TDP-43 and FUS occurs independently of Exportin-1/CRM1. Sci. Rep. 8, 7084 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935713</ArticleId><ArticleId IdType="pubmed">29728564</ArticleId></ArticleIdList></Reference><Reference><Citation>E. S.&#xa0;Pinarbasi, T.&#xa0;Cagatay, H.&#xa0;Y.&#xa0;J.&#xa0;Fung, Y. C.&#xa0;Li, Y. M.&#xa0;Chook, P. J.&#xa0;Thomas, Active nuclear import and passive nuclear export are the primary determinants of TDP-43 localization. Sci. Rep. 8, 7083 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935693</ArticleId><ArticleId IdType="pubmed">29728608</ArticleId></ArticleIdList></Reference><Reference><Citation>T.&#xa0;Nonaka, M.&#xa0;Masuda-Suzukake, T.&#xa0;Arai, Y.&#xa0;Hasegawa, H.&#xa0;Akatsu, T.&#xa0;Obi, M.&#xa0;Yoshida, S.&#xa0;Murayama, D. M.&#xa0;Mann, H.&#xa0;Akiyama, M.&#xa0;Hasegawa, Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 4, 124&#x2013;134 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23831027</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Shimonaka, T.&#xa0;Nonaka, G.&#xa0;Suzuki, S.&#xa0;Hisanaga, M.&#xa0;Hasegawa, Templated aggregation of TAR DNA-binding protein of 43 kDa (TDP-43) by seeding with TDP-43 peptide fibrils. J. Biol. Chem. 291, 8896&#x2013;8907 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4861459</ArticleId><ArticleId IdType="pubmed">26887947</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Porta, Y.&#xa0;Xu, C. R.&#xa0;Restrepo, L. K.&#xa0;Kwong, B.&#xa0;Zhang, H. J.&#xa0;Brown, E. B.&#xa0;Lee, J. Q.&#xa0;Trojanowski, V. M.&#xa0;Lee, Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat. Commun. 9, 4220 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6181940</ArticleId><ArticleId IdType="pubmed">30310141</ArticleId></ArticleIdList></Reference><Reference><Citation>M.&#xa0;Yamashita, T.&#xa0;Nonaka, S.&#xa0;Hirai, A.&#xa0;Miwa, H.&#xa0;Okado, T.&#xa0;Arai, M.&#xa0;Hosokawa, H.&#xa0;Akiyama, M.&#xa0;Hasegawa, Distinct pathways leading to TDP-43-induced cellular dysfunctions. Hum. Mol. Genet. 23, 4345&#x2013;4356 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24698978</ArticleId></ArticleIdList></Reference><Reference><Citation>E.&#xa0;Buratti, T.&#xa0;Dork, E.&#xa0;Zuccato, F.&#xa0;Pagani, M.&#xa0;Romano, F. E.&#xa0;Baralle, Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 20, 1774&#x2013;1784 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC145463</ArticleId><ArticleId IdType="pubmed">11285240</ArticleId></ArticleIdList></Reference><Reference><Citation>M.&#xa0;Polymenidou, C.&#xa0;Lagier-Tourenne, K. R.&#xa0;Hutt, S. C.&#xa0;Huelga, J.&#xa0;Moran, T. Y.&#xa0;Liang, S. C.&#xa0;Ling, E.&#xa0;Sun, E.&#xa0;Wancewicz, C.&#xa0;Mazur, H.&#xa0;Kordasiewicz, Y.&#xa0;Sedaghat, J. P.&#xa0;Donohue, L.&#xa0;Shiue, C. F.&#xa0;Bennett, G. W.&#xa0;Yeo, D. W.&#xa0;Cleveland, Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 14, 459&#x2013;468 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Watanabe, K.&#xa0;Oiwa, Y.&#xa0;Murata, O.&#xa0;Komine, A.&#xa0;Sobue, F.&#xa0;Endo, E.&#xa0;Takahashi, K.&#xa0;Yamanaka, ALS-linked TDP-43(M337V) knock-in mice exhibit splicing deregulation without neurodegeneration. Mol. Brain 13, 8 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6971932</ArticleId><ArticleId IdType="pubmed">31959210</ArticleId></ArticleIdList></Reference><Reference><Citation>Y. M.&#xa0;Ayala, P.&#xa0;Zago, A.&#xa0;D'Ambrogio, Y. F.&#xa0;Xu, L.&#xa0;Petrucelli, E.&#xa0;Buratti, F. E.&#xa0;Baralle, Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 121, 3778&#x2013;3785 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18957508</ArticleId></ArticleIdList></Reference><Reference><Citation>F.&#xa0;Hans, H.&#xa0;Glasebach, P. J.&#xa0;Kahle, Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granules. J. Biol. Chem. 295, 673&#x2013;689 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970928</ArticleId><ArticleId IdType="pubmed">31780563</ArticleId></ArticleIdList></Reference><Reference><Citation>Y. R.&#xa0;Li, O. D.&#xa0;King, J.&#xa0;Shorter, A. D.&#xa0;Gitler, Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 201, 361&#x2013;372 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>J.&#xa0;van Eersel, Y. D.&#xa0;Ke, A.&#xa0;Gladbach, M.&#xa0;Bi, J.&#xa0;Gotz, J. J.&#xa0;Kril, L. M.&#xa0;Ittner, Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons. PLOS ONE 6, e22850 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3146516</ArticleId><ArticleId IdType="pubmed">21829535</ArticleId></ArticleIdList></Reference><Reference><Citation>X.&#xa0;Zuo, J.&#xa0;Zhou, Y.&#xa0;Li, K.&#xa0;Wu, Z.&#xa0;Chen, Z.&#xa0;Luo, X.&#xa0;Zhang, Y.&#xa0;Liang, M. A.&#xa0;Esteban, Y.&#xa0;Zhou, X. D.&#xa0;Fu, TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS. Nat. Struct. Mol. Biol. 28, 132&#x2013;142 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33398173</ArticleId></ArticleIdList></Reference><Reference><Citation>H.&#xa0;Tsuiji, Y.&#xa0;Iguchi, A.&#xa0;Furuya, A.&#xa0;Kataoka, H.&#xa0;Hatsuta, N.&#xa0;Atsuta, F.&#xa0;Tanaka, Y.&#xa0;Hashizume, H.&#xa0;Akatsu, S.&#xa0;Murayama, G.&#xa0;Sobue, K.&#xa0;Yamanaka, Spliceosome integrity is defective in the motor neuron diseases ALS and SMA. EMBO Mol. Med. 5, 221&#x2013;234 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3569639</ArticleId><ArticleId IdType="pubmed">23255347</ArticleId></ArticleIdList></Reference><Reference><Citation>M.&#xa0;Neumann, L. K.&#xa0;Kwong, E. B.&#xa0;Lee, E.&#xa0;Kremmer, A.&#xa0;Flatley, Y.&#xa0;Xu, M. S.&#xa0;Forman, D.&#xa0;Troost, H. A.&#xa0;Kretzschmar, J. Q.&#xa0;Trojanowski, V. M.&#xa0;Lee, Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 117, 137&#x2013;149 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>M.&#xa0;Hasegawa, T.&#xa0;Arai, T.&#xa0;Nonaka, F.&#xa0;Kametani, M.&#xa0;Yoshida, Y.&#xa0;Hashizume, T. G.&#xa0;Beach, E.&#xa0;Buratti, F.&#xa0;Baralle, M.&#xa0;Morita, I.&#xa0;Nakano, T.&#xa0;Oda, K.&#xa0;Tsuchiya, H.&#xa0;Akiyama, Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 64, 60&#x2013;70 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>T. J.&#xa0;Cohen, A. W.&#xa0;Hwang, C. R.&#xa0;Restrepo, C. X.&#xa0;Yuan, J. Q.&#xa0;Trojanowski, V. M.&#xa0;Lee, An acetylation switch controls TDP-43 function and aggregation propensity. Nat. Commun. 6, 5845 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4407365</ArticleId><ArticleId IdType="pubmed">25556531</ArticleId></ArticleIdList></Reference><Reference><Citation>C.&#xa0;Foglieni, S.&#xa0;Papin, A.&#xa0;Salvade, T.&#xa0;Afroz, S.&#xa0;Pinton, G.&#xa0;Pedrioli, G.&#xa0;Ulrich, M.&#xa0;Polymenidou, P.&#xa0;Paganetti, Split GFP technologies to structurally characterize and quantify functional biomolecular interactions of FTD-related proteins. Sci. Rep. 7, 14013 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5656600</ArticleId><ArticleId IdType="pubmed">29070802</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Sakai, S.&#xa0;Watanabe, O.&#xa0;Komine, A.&#xa0;Sobue, K.&#xa0;Yamanaka, Novel reporters of mitochondria-associated membranes (MAM), MAMtrackers, demonstrate MAM disruption as a common pathological feature in amyotrophic lateral sclerosis. FASEB J. 35, e21688 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34143516</ArticleId></ArticleIdList></Reference><Reference><Citation>A. S.&#xa0;Dixon, M. K.&#xa0;Schwinn, M. P.&#xa0;Hall, K.&#xa0;Zimmerman, P.&#xa0;Otto, T. H.&#xa0;Lubben, B. L.&#xa0;Butler, B. F.&#xa0;Binkowski, T.&#xa0;Machleidt, T. A.&#xa0;Kirkland, M. G.&#xa0;Wood, C. T.&#xa0;Eggers, L. P.&#xa0;Encell, K. V.&#xa0;Wood, NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells. ACS Chem. Biol. 11, 400&#x2013;408 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26569370</ArticleId></ArticleIdList></Reference><Reference><Citation>T.&#xa0;Ishihara, Y.&#xa0;Ariizumi, A.&#xa0;Shiga, T.&#xa0;Kato, C. F.&#xa0;Tan, T.&#xa0;Sato, Y.&#xa0;Miki, M.&#xa0;Yokoo, T.&#xa0;Fujino, A.&#xa0;Koyama, A.&#xa0;Yokoseki, M.&#xa0;Nishizawa, A.&#xa0;Kakita, H.&#xa0;Takahashi, O.&#xa0;Onodera, Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 4136&#x2013;4147 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23740936</ArticleId></ArticleIdList></Reference><Reference><Citation>V.&#xa0;Romano, Z.&#xa0;Quadri, F. E.&#xa0;Baralle, E.&#xa0;Buratti, The structural integrity of TDP-43 N-terminus is required for efficient aggregate entrapment and consequent loss of protein function. Prion 9, 1&#x2013;9 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4601194</ArticleId><ArticleId IdType="pubmed">25635624</ArticleId></ArticleIdList></Reference><Reference><Citation>B.&#xa0;Bolognesi, A. J.&#xa0;Faure, M.&#xa0;Seuma, J. M.&#xa0;Schmiedel, G. G.&#xa0;Tartaglia, B.&#xa0;Lehner, The mutational landscape of a prion-like domain. Nat. Commun. 10, 4162 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6744496</ArticleId><ArticleId IdType="pubmed">31519910</ArticleId></ArticleIdList></Reference><Reference><Citation>L. A.&#xa0;Gruijs da Silva, F.&#xa0;Simonetti, S.&#xa0;Hutten, H.&#xa0;Riemenschneider, E. L.&#xa0;Sternburg, L. M.&#xa0;Pietrek, J.&#xa0;Gebel, V.&#xa0;Dotsch, D.&#xa0;Edbauer, G.&#xa0;Hummer, L. S.&#xa0;Stelzl, D.&#xa0;Dormann, Disease-linked TDP-43 hyperphosphorylation suppresses TDP-43 condensation and aggregation. EMBO J. 41, e108443 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9016352</ArticleId><ArticleId IdType="pubmed">35112738</ArticleId></ArticleIdList></Reference><Reference><Citation>M. J.&#xa0;Winton, L. M.&#xa0;Igaz, M. M.&#xa0;Wong, L. K.&#xa0;Kwong, J. Q.&#xa0;Trojanowski, V. M.&#xa0;Lee, Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 283, 13302&#x2013;13309 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>A. L.&#xa0;Nishimura, V.&#xa0;Zupunski, C.&#xa0;Troakes, C.&#xa0;Kathe, P.&#xa0;Fratta, M.&#xa0;Howell, J. M.&#xa0;Gallo, T.&#xa0;Hortobagyi, C. E.&#xa0;Shaw, B.&#xa0;Rogelj, Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration. Brain 133, 1763&#x2013;1771 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20472655</ArticleId></ArticleIdList></Reference><Reference><Citation>L.&#xa0;Duan, B. L.&#xa0;Zaepfel, V.&#xa0;Aksenova, M.&#xa0;Dasso, J. D.&#xa0;Rothstein, P.&#xa0;Kalab, L. R.&#xa0;Hayes, Nuclear RNA binding regulates TDP-43 nuclear localization and passive nuclear export. Cell Rep. 40, 111106 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9345261</ArticleId><ArticleId IdType="pubmed">35858577</ArticleId></ArticleIdList></Reference><Reference><Citation>H. C.&#xa0;Archbold, K. L.&#xa0;Jackson, A.&#xa0;Arora, K.&#xa0;Weskamp, E. M.&#xa0;Tank, X.&#xa0;Li, R.&#xa0;Miguez, R. D.&#xa0;Dayton, S.&#xa0;Tamir, R. L.&#xa0;Klein, S. J.&#xa0;Barmada, TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia. Sci. Rep. 8, 4606 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5854632</ArticleId><ArticleId IdType="pubmed">29545601</ArticleId></ArticleIdList></Reference><Reference><Citation>B. D.&#xa0;Freibaum, R. K.&#xa0;Chitta, A. A.&#xa0;High, J. P.&#xa0;Taylor, Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J. Proteome Res. 9, 1104&#x2013;1120 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2897173</ArticleId><ArticleId IdType="pubmed">20020773</ArticleId></ArticleIdList></Reference><Reference><Citation>X. Y.&#xa0;Zhong, P.&#xa0;Wang, J.&#xa0;Han, M. G.&#xa0;Rosenfeld, X. D.&#xa0;Fu, SR proteins in vertical integration of gene expression from transcription to RNA processing to translation. Mol. Cell 35, 1&#x2013;10 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2744344</ArticleId><ArticleId IdType="pubmed">19595711</ArticleId></ArticleIdList></Reference><Reference><Citation>T.&#xa0;Maniatis, R.&#xa0;Reed, An extensive network of coupling among gene expression machines. Nature 416, 499&#x2013;506 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11932736</ArticleId></ArticleIdList></Reference><Reference><Citation>C.&#xa0;Fallini, G. J.&#xa0;Bassell, W.&#xa0;Rossoll, The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Hum. Mol. Genet. 21, 3703&#x2013;3718 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3406762</ArticleId><ArticleId IdType="pubmed">22641816</ArticleId></ArticleIdList></Reference><Reference><Citation>N. H.&#xa0;Alami, R. B.&#xa0;Smith, M. A.&#xa0;Carrasco, L. A.&#xa0;Williams, C. S.&#xa0;Winborn, S.&#xa0;S.&#xa0;W.&#xa0;Han, E.&#xa0;Kiskinis, B.&#xa0;Winborn, B. D.&#xa0;Freibaum, A.&#xa0;Kanagaraj, A. J.&#xa0;Clare, N. M.&#xa0;Badders, B.&#xa0;Bilican, E.&#xa0;Chaum, S.&#xa0;Chandran, C. E.&#xa0;Shaw, K. C.&#xa0;Eggan, T.&#xa0;Maniatis, J. P.&#xa0;Taylor, Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron 81, 536&#x2013;543 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>D. A.&#xa0;Solomon, A.&#xa0;Stepto, W. H.&#xa0;Au, Y.&#xa0;Adachi, D. C.&#xa0;Diaper, R.&#xa0;Hall, A.&#xa0;Rekhi, A.&#xa0;Boudi, P.&#xa0;Tziortzouda, Y. B.&#xa0;Lee, B.&#xa0;Smith, J. C.&#xa0;Bridi, G.&#xa0;Spinelli, J.&#xa0;Dearlove, D. M.&#xa0;Humphrey, J. M.&#xa0;Gallo, C.&#xa0;Troakes, M.&#xa0;Fanto, M.&#xa0;Soller, B.&#xa0;Rogelj, R. B.&#xa0;Parsons, C. E.&#xa0;Shaw, T.&#xa0;Hortobagyi, F.&#xa0;Hirth, A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-&#x3b1; mediates C9orf72-related neurodegeneration. Brain 141, 2908&#x2013;2924 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6158706</ArticleId><ArticleId IdType="pubmed">30239641</ArticleId></ArticleIdList></Reference><Reference><Citation>L.&#xa0;Guo, H. J.&#xa0;Kim, H.&#xa0;Wang, J.&#xa0;Monaghan, F.&#xa0;Freyermuth, J. C.&#xa0;Sung, K.&#xa0;O'Donovan, C. M.&#xa0;Fare, Z.&#xa0;Diaz, N.&#xa0;Singh, Z. C.&#xa0;Zhang, M.&#xa0;Coughlin, E. A.&#xa0;Sweeny, M. E.&#xa0;DeSantis, M. E.&#xa0;Jackrel, C. B.&#xa0;Rodell, J. A.&#xa0;Burdick, O. D.&#xa0;King, A. D.&#xa0;Gitler, C.&#xa0;Lagier-Tourenne, U. B.&#xa0;Pandey, Y. M.&#xa0;Chook, J. P.&#xa0;Taylor, J.&#xa0;Shorter, Nuclear-import receptors reverse aberrant phase transitions of RNA-binding proteins with prion-like domains. Cell 173, 677&#x2013;692.e20 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5911940</ArticleId><ArticleId IdType="pubmed">29677512</ArticleId></ArticleIdList></Reference><Reference><Citation>C. C.&#xa0;Chou, Y.&#xa0;Zhang, M. E.&#xa0;Umoh, S. W.&#xa0;Vaughan, I.&#xa0;Lorenzini, F.&#xa0;Liu, M.&#xa0;Sayegh, P. G.&#xa0;Donlin-Asp, Y. H.&#xa0;Chen, D. M.&#xa0;Duong, N. T.&#xa0;Seyfried, M. A.&#xa0;Powers, T.&#xa0;Kukar, C. M.&#xa0;Hales, M.&#xa0;Gearing, N. J.&#xa0;Cairns, K. B.&#xa0;Boylan, D. W.&#xa0;Dickson, R.&#xa0;Rademakers, Y. J.&#xa0;Zhang, L.&#xa0;Petrucelli, R.&#xa0;Sattler, D. C.&#xa0;Zarnescu, J. D.&#xa0;Glass, W.&#xa0;Rossoll, TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 21, 228&#x2013;239 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>A. C.&#xa0;Woerner, F.&#xa0;Frottin, D.&#xa0;Hornburg, L. R.&#xa0;Feng, F.&#xa0;Meissner, M.&#xa0;Patra, J.&#xa0;Tatzelt, M.&#xa0;Mann, K. F.&#xa0;Winklhofer, F. U.&#xa0;Hartl, M. S.&#xa0;Hipp, Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA. Science 351, 173&#x2013;176 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26634439</ArticleId></ArticleIdList></Reference><Reference><Citation>T.&#xa0;Philips, J. D.&#xa0;Rothstein, Rodent models of amyotrophic lateral sclerosis. Curr. Protoc. Pharmacol. 69, 5.67.1&#x2013;5.67.21 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4562058</ArticleId><ArticleId IdType="pubmed">26344214</ArticleId></ArticleIdList></Reference><Reference><Citation>A.&#xa0;Koyama, A.&#xa0;Sugai, T.&#xa0;Kato, T.&#xa0;Ishihara, A.&#xa0;Shiga, Y.&#xa0;Toyoshima, M.&#xa0;Koyama, T.&#xa0;Konno, S.&#xa0;Hirokawa, A.&#xa0;Yokoseki, M.&#xa0;Nishizawa, A.&#xa0;Kakita, H.&#xa0;Takahashi, O.&#xa0;Onodera, Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43. Nucleic Acids Res. 44, 5820&#x2013;5836 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4937342</ArticleId><ArticleId IdType="pubmed">27257061</ArticleId></ArticleIdList></Reference><Reference><Citation>B.&#xa0;Bilican, A.&#xa0;Serio, S. J.&#xa0;Barmada, A. L.&#xa0;Nishimura, G. J.&#xa0;Sullivan, M.&#xa0;Carrasco, H. P.&#xa0;Phatnani, C. A.&#xa0;Puddifoot, D.&#xa0;Story, J.&#xa0;Fletcher, I. H.&#xa0;Park, B. A.&#xa0;Friedman, G. Q.&#xa0;Daley, D. J.&#xa0;Wyllie, G. E.&#xa0;Hardingham, I.&#xa0;Wilmut, S.&#xa0;Finkbeiner, T.&#xa0;Maniatis, C. E.&#xa0;Shaw, S.&#xa0;Chandran, Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc. Natl. Acad. Sci. U.S.A. 109, 5803&#x2013;5808 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3326463</ArticleId><ArticleId IdType="pubmed">22451909</ArticleId></ArticleIdList></Reference><Reference><Citation>M. A.&#xa0;White, E.&#xa0;Kim, A.&#xa0;Duffy, R.&#xa0;Adalbert, B. U.&#xa0;Phillips, O. M.&#xa0;Peters, J.&#xa0;Stephenson, S.&#xa0;Yang, F.&#xa0;Massenzio, Z.&#xa0;Lin, S.&#xa0;Andrews, A.&#xa0;Segonds-Pichon, J.&#xa0;Metterville, L. M.&#xa0;Saksida, R.&#xa0;Mead, R. R.&#xa0;Ribchester, Y.&#xa0;Barhomi, T.&#xa0;Serre, M. P.&#xa0;Coleman, J. R.&#xa0;Fallon, T. J.&#xa0;Bussey, R. H.&#xa0;Brown Jr., J.&#xa0;Sreedharan, TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD. Nat. Neurosci. 21, 552&#x2013;563 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5884423</ArticleId><ArticleId IdType="pubmed">29556029</ArticleId></ArticleIdList></Reference><Reference><Citation>Y.&#xa0;Iguchi, M.&#xa0;Katsuno, J.&#xa0;Niwa, S.&#xa0;Takagi, S.&#xa0;Ishigaki, K.&#xa0;Ikenaka, K.&#xa0;Kawai, H.&#xa0;Watanabe, K.&#xa0;Yamanaka, R.&#xa0;Takahashi, H.&#xa0;Misawa, S.&#xa0;Sasaki, F.&#xa0;Tanaka, G.&#xa0;Sobue, Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain 136, 1371&#x2013;1382 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23449777</ArticleId></ArticleIdList></Reference><Reference><Citation>L. S.&#xa0;Wu, W. C.&#xa0;Cheng, C. K.&#xa0;Shen, Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice. J. Biol. Chem. 287, 27335&#x2013;27344 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3431639</ArticleId><ArticleId IdType="pubmed">22718760</ArticleId></ArticleIdList></Reference><Reference><Citation>J. P.&#xa0;Ling, O.&#xa0;Pletnikova, J. C.&#xa0;Troncoso, P. C.&#xa0;Wong, TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science 349, 650&#x2013;655 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>J. R.&#xa0;Klim, L. A.&#xa0;Williams, F.&#xa0;Limone, I.&#xa0;G.&#xa0;S.&#xa0;Juan, B. N.&#xa0;Davis-Dusenbery, D. A.&#xa0;Mordes, A.&#xa0;Burberry, M. J.&#xa0;Steinbaugh, K. K.&#xa0;Gamage, R.&#xa0;Kirchner, R.&#xa0;Moccia, S. H.&#xa0;Cassel, K.&#xa0;Chen, B. J.&#xa0;Wainger, C. J.&#xa0;Woolf, K.&#xa0;Eggan, ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 22, 167&#x2013;179 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Z.&#xa0;Melamed, J.&#xa0;Lopez-Erauskin, M. W.&#xa0;Baughn, O.&#xa0;Zhang, K.&#xa0;Drenner, Y.&#xa0;Sun, F.&#xa0;Freyermuth, M. A.&#xa0;McMahon, M. S.&#xa0;Beccari, J. W.&#xa0;Artates, T.&#xa0;Ohkubo, M.&#xa0;Rodriguez, N.&#xa0;Lin, D.&#xa0;Wu, C. F.&#xa0;Bennett, F.&#xa0;Rigo, S.&#xa0;Da Cruz, J.&#xa0;Ravits, C.&#xa0;Lagier-Tourenne, D. W.&#xa0;Cleveland, Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 22, 180&#x2013;190 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>A. L.&#xa0;Brown, O. G.&#xa0;Wilkins, M. J.&#xa0;Keuss, S. E.&#xa0;Hill, M.&#xa0;Zanovello, W. C.&#xa0;Lee, A.&#xa0;Bampton, F.&#xa0;C.&#xa0;Y.&#xa0;Lee, L.&#xa0;Masino, Y. A.&#xa0;Qi, S.&#xa0;Bryce-Smith, A.&#xa0;Gatt, M.&#xa0;Hallegger, D.&#xa0;Fagegaltier, H.&#xa0;Phatnani, N. A.&#xa0;Consortium, J.&#xa0;Newcombe, E. K.&#xa0;Gustavsson, S.&#xa0;Seddighi, J. F.&#xa0;Reyes, S. L.&#xa0;Coon, D.&#xa0;Ramos, G.&#xa0;Schiavo, E.&#xa0;M.&#xa0;C.&#xa0;Fisher, T.&#xa0;Raj, M.&#xa0;Secrier, T.&#xa0;Lashley, J.&#xa0;Ule, E.&#xa0;Buratti, J.&#xa0;Humphrey, M. E.&#xa0;Ward, P.&#xa0;Fratta, TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature 603, 131&#x2013;137 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8891020</ArticleId><ArticleId IdType="pubmed">35197628</ArticleId></ArticleIdList></Reference><Reference><Citation>X. R.&#xa0;Ma, M.&#xa0;Prudencio, Y.&#xa0;Koike, S. C.&#xa0;Vatsavayai, G.&#xa0;Kim, F.&#xa0;Harbinski, A.&#xa0;Briner, C. M.&#xa0;Rodriguez, C.&#xa0;Guo, T.&#xa0;Akiyama, H. B.&#xa0;Schmidt, B. B.&#xa0;Cummings, D. W.&#xa0;Wyatt, K.&#xa0;Kurylo, G.&#xa0;Miller, S.&#xa0;Mekhoubad, N.&#xa0;Sallee, G.&#xa0;Mekonnen, L.&#xa0;Ganser, J. D.&#xa0;Rubien, K.&#xa0;Jansen-West, C. N.&#xa0;Cook, S.&#xa0;Pickles, B.&#xa0;Oskarsson, N. R.&#xa0;Graff-Radford, B. F.&#xa0;Boeve, D. S.&#xa0;Knopman, R. C.&#xa0;Petersen, D. W.&#xa0;Dickson, J.&#xa0;Shorter, S.&#xa0;Myong, E. M.&#xa0;Green, W. W.&#xa0;Seeley, L.&#xa0;Petrucelli, A. D.&#xa0;Gitler, TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature 603, 124&#x2013;130 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8891019</ArticleId><ArticleId IdType="pubmed">35197626</ArticleId></ArticleIdList></Reference><Reference><Citation>F.&#xa0;Gasset-Rosa, S.&#xa0;Lu, H.&#xa0;Yu, C.&#xa0;Chen, Z.&#xa0;Melamed, L.&#xa0;Guo, J.&#xa0;Shorter, S.&#xa0;Da Cruz, D. W.&#xa0;Cleveland, Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron 102, 339&#x2013;357.e7 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>R.&#xa0;Rakhit, J. P.&#xa0;Crow, J. R.&#xa0;Lepock, L. H.&#xa0;Kondejewski, N. R.&#xa0;Cashman, A.&#xa0;Chakrabartty, Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J. Biol. Chem. 279, 15499&#x2013;15504 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14734542</ArticleId></ArticleIdList></Reference><Reference><Citation>M. J.&#xa0;Lindberg, R.&#xa0;Bystrom, N.&#xa0;Boknas, P. M.&#xa0;Andersen, M.&#xa0;Oliveberg, Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants. Proc. Natl. Acad. Sci. U.S.A. 102, 9754&#x2013;9759 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1174986</ArticleId><ArticleId IdType="pubmed">15987780</ArticleId></ArticleIdList></Reference><Reference><Citation>U.&#xa0;Dettmer, A. J.&#xa0;Newman, F.&#xa0;Soldner, E. S.&#xa0;Luth, N. C.&#xa0;Kim, V. E.&#xa0;von Saucken, J. B.&#xa0;Sanderson, R.&#xa0;Jaenisch, T.&#xa0;Bartels, D.&#xa0;Selkoe, Parkinson-causing &#x3b1;-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat. Commun. 6, 7314 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4490410</ArticleId><ArticleId IdType="pubmed">26076669</ArticleId></ArticleIdList></Reference><Reference><Citation>T.&#xa0;Bartels, J. G.&#xa0;Choi, D. J.&#xa0;Selkoe, &#x3b1;-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477, 107&#x2013;110 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3166366</ArticleId><ArticleId IdType="pubmed">21841800</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Nuber, M.&#xa0;Rajsombath, G.&#xa0;Minakaki, J.&#xa0;Winkler, C. P.&#xa0;Muller, M.&#xa0;Ericsson, B.&#xa0;Caldarone, U.&#xa0;Dettmer, D. J.&#xa0;Selkoe, Abrogating native &#x3b1;-synuclein tetramers in mice causes a L-DOPA-responsive motor syndrome closely resembling Parkinson's disease. Neuron 100, 75&#x2013;90.e5 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6211795</ArticleId><ArticleId IdType="pubmed">30308173</ArticleId></ArticleIdList></Reference><Reference><Citation>B. R.&#xa0;Brooks, R. G.&#xa0;Miller, M.&#xa0;Swash, T. L.&#xa0;Munsat, D., El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1, 293&#x2013;299 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>D.&#xa0;Neary, J. S.&#xa0;Snowden, L.&#xa0;Gustafson, U.&#xa0;Passant, D.&#xa0;Stuss, S.&#xa0;Black, M.&#xa0;Freedman, A.&#xa0;Kertesz, P. H.&#xa0;Robert, M.&#xa0;Albert, K.&#xa0;Boone, B. L.&#xa0;Miller, J.&#xa0;Cummings, D. F.&#xa0;Benson, Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51, 1546&#x2013;1554 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9855500</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Watanabe, H.&#xa0;Inami, K.&#xa0;Oiwa, Y.&#xa0;Murata, S.&#xa0;Sakai, O.&#xa0;Komine, A.&#xa0;Sobue, Y.&#xa0;Iguchi, M.&#xa0;Katsuno, K.&#xa0;Yamanaka, Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43. Cell Death Dis. 11, 909 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7585435</ArticleId><ArticleId IdType="pubmed">33097688</ArticleId></ArticleIdList></Reference><Reference><Citation>K.&#xa0;Takahashi, K.&#xa0;Tanabe, M.&#xa0;Ohnuki, M.&#xa0;Narita, T.&#xa0;Ichisaka, K.&#xa0;Tomoda, S.&#xa0;Yamanaka, Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861&#x2013;872 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">18035408</ArticleId></ArticleIdList></Reference><Reference><Citation>D.&#xa0;Shimojo, K.&#xa0;Onodera, Y.&#xa0;Doi-Torii, Y.&#xa0;Ishihara, C.&#xa0;Hattori, Y.&#xa0;Miwa, S.&#xa0;Tanaka, R.&#xa0;Okada, M.&#xa0;Ohyama, M.&#xa0;Shoji, A.&#xa0;Nakanishi, M.&#xa0;Doyu, H.&#xa0;Okano, Y.&#xa0;Okada, Rapid, efficient, and simple motor neuron differentiation from human pluripotent stem cells. Mol. Brain 8, 79 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4666063</ArticleId><ArticleId IdType="pubmed">26626025</ArticleId></ArticleIdList></Reference><Reference><Citation>Y.&#xa0;Okada, A.&#xa0;Matsumoto, T.&#xa0;Shimazaki, R.&#xa0;Enoki, A.&#xa0;Koizumi, S.&#xa0;Ishii, Y.&#xa0;Itoyama, G.&#xa0;Sobue, H.&#xa0;Okano, Spatiotemporal recapitulation of central nervous system development by murine embryonic stem cell-derived neural stem/progenitor cells. Stem Cells 26, 3086&#x2013;3098 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18757299</ArticleId></ArticleIdList></Reference><Reference><Citation>T.&#xa0;Nagai, K.&#xa0;Ibata, E. S.&#xa0;Park, M.&#xa0;Kubota, K.&#xa0;Mikoshiba, A.&#xa0;Miyawaki, A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 20, 87&#x2013;90 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11753368</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Watanabe, K.&#xa0;Kaneko, K.&#xa0;Yamanaka, Accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43 proteins. J. Biol. Chem. 288, 3641&#x2013;3654 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3561582</ArticleId><ArticleId IdType="pubmed">23235148</ArticleId></ArticleIdList></Reference><Reference><Citation>A.&#xa0;D'Ambrogio, E.&#xa0;Buratti, C.&#xa0;Stuani, C.&#xa0;Guarnaccia, M.&#xa0;Romano, Y. M.&#xa0;Ayala, F. E.&#xa0;Baralle, Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo. Nucleic Acids Res. 37, 4116&#x2013;4126 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2709582</ArticleId><ArticleId IdType="pubmed">19429692</ArticleId></ArticleIdList></Reference><Reference><Citation>F.&#xa0;Pagani, E.&#xa0;Buratti, C.&#xa0;Stuani, M.&#xa0;Romano, E.&#xa0;Zuccato, M.&#xa0;Niksic, L.&#xa0;Giglio, D.&#xa0;Faraguna, F. E.&#xa0;Baralle, Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element. J. Biol. Chem. 275, 21041&#x2013;21047 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10766763</ArticleId></ArticleIdList></Reference><Reference><Citation>M.&#xa0;Mirdita, K.&#xa0;Schutze, Y.&#xa0;Moriwaki, L.&#xa0;Heo, S.&#xa0;Ovchinnikov, M.&#xa0;Steinegger, ColabFold: Making protein folding accessible to all. Nat. Methods 19, 679&#x2013;682 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9184281</ArticleId><ArticleId IdType="pubmed">35637307</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>